Cardiovascular & Hematological Agents in Medicinal Chemistry
Title:Acknowledgements to Reviewers
Volume: 17 Issue: 2
Author(s):
Affiliation:
Export Options
About this article
Cite this article as:
, Acknowledgements to Reviewers, Cardiovascular & Hematological Agents in Medicinal Chemistry 2019; 17 (2) . https://dx.doi.org/10.2174/187152571702191102141948
DOI https://dx.doi.org/10.2174/187152571702191102141948 |
Print ISSN 1871-5257 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6182 |
Article Metrics
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Death Receptors as Targets of Cancer Therapeutics
Current Cancer Drug Targets Caspase-1-independent Maturation of IL-1β in Ischemic Brain Injury: is there a Role for Gelatinases?
Mini-Reviews in Medicinal Chemistry Descriptive Analysis of Mortality Predictors in H1n1 Influenza in South Indian Patients
Infectious Disorders - Drug Targets Insight to the Pathophysiology of Stable Angina Pectoris
Current Pharmaceutical Design PKC Delta and Epsilon in Drug Targeting and Therapeutics
Recent Patents on DNA & Gene Sequences Urine Albumin/Creatinine Ratio, High Sensitivity C-Reactive Protein and N-Terminal Pro Brain Natriuretic Peptide - Three New Cardiovascular Risk Markers - Do They Improve Risk Prediction and Influence Treatment?
Current Vascular Pharmacology Oligonucleotide-Based Molecular Therapy for Restenosis after Angioplasty
Current Drug Targets Scutellarin Mediates Cytochrome P450 3A4 and 2C19 Expression via Pregnane X Receptor and Constitutive Androstane Receptor
Current Molecular Pharmacology Editorial (Thematic Issue: Cardiovascular Prevention: Can We Do Any Better?)
Current Pharmaceutical Design Efficacy and Cardiovascular Safety of Antidiabetic Medications
Current Drug Safety Assessment Relation of Myocardial Detector Counts and Administered Activity of <sup>99m</sup>Tc-SestaMIBI in MPI: The Effects of Body Weight, BMI, and Gender
Current Radiopharmaceuticals Study on Maternal and Neonatal Outcome of Women Undergoing Caesarean Section using NICE Classification in a Tertiary Care Hospital in Rural Area of Central India - An Observational Prospective Study
Current Women`s Health Reviews Graft Patency Assessment with CCTA Using a Comprehensive Singlebranch Bridging Score
Current Medical Imaging Variability in Response to Cardiovascular Drugs
Current Clinical Pharmacology The Neurophysiology of Hydrogen Sulfide
Inflammation & Allergy - Drug Targets (Discontinued) Design and Synthesis of 3-Arylisoxazoline-5-Carboxamide and 3-Arylisoxazoline-5-Acetamide Libraries as Potential Factor Xa Inhibitors
Letters in Drug Design & Discovery The Hippocampal Autophagic Machinery is Depressed in the Absence of the Circadian Clock Protein PER1 that may Lead to Vulnerability During Cerebral Ischemia
Current Neurovascular Research New Immunosuppressants in Clinical Trial
Current Drug Targets - Cardiovascular & Hematological Disorders Cell Therapy for Respiratory Diseases: Optimizing Cell Delivery Strategies
Current Respiratory Medicine Reviews Ticagrelor in ST-Elevation Myocardial Infarction
Current Vascular Pharmacology